Dreams sometimes really do come true. The kid that everyone dismisses as a regular daydreamer can change the world with their unconventional ideas. It’s even possible for the child who was obsessed with space travel and other crazy thoughts to turn these dreams into reality. Entrepreneur and billionaire Elon Musk is the embodiment of this type of dreamer. He took the electric cars and space travel he imagined as a child and is working towards making those dreams become a reality. Tesla is now a nearly $43 billion company and SpaceX stock could one day be the next hot IPO. Read More

Dreams sometimes really do come true. The kid that everyone dismisses as a regular daydreamer can change the world with their unconventional ideas. It’s even possible for the child who was obsessed with space travel and other crazy thoughts to turn these dreams into reality. Entrepreneur and billionaire Elon Musk is the embodiment of this type of dreamer. He took the electric cars and space travel he imagined as a child and is working towards making those dreams become a reality. Tesla is now a nearly $43 billion company and SpaceX stock could one day be the next hot IPO. It is nearly certain that Musk takes this same forward-looking approach when investing his own money. I’m very curious about the latest positions taken by this business genius, especially with all the recent publicity on SpaceX. How Musk Made His Fortune Elon was born in Australia in 1971 and hit the global wealthy list in 1999 with the sale of his first company, Zip2, to Compaq for $307 million (of which Musk received $22 million). Rather than relax on the beach for the rest of his life, he used this money to pursue his dreams of changing the world. Read More

There are a lot of hard problems facing Washington. Healthcare will take time, as will many other issues. Tax policy seems to offer the most immediate path to a significant accomplishment for the president and Congress. President Donald Trump has made a number of proposals related to taxes. Among the most important would be a reduction in the highest corporate income tax rate from 35% to 15%. I am fairly certain tax reform will require negotiations and Trump won’t get everything he wants. But the good news is that lower corporate and personal income taxes seem likely. #-ad_banner-#Lower corporate taxes… Read More

There are a lot of hard problems facing Washington. Healthcare will take time, as will many other issues. Tax policy seems to offer the most immediate path to a significant accomplishment for the president and Congress. President Donald Trump has made a number of proposals related to taxes. Among the most important would be a reduction in the highest corporate income tax rate from 35% to 15%. I am fairly certain tax reform will require negotiations and Trump won’t get everything he wants. But the good news is that lower corporate and personal income taxes seem likely. #-ad_banner-#Lower corporate taxes will have an immediate impact on company earnings. Standard & Poor’s estimates that every 1% reduction in the corporate tax rate could add 1% to the earnings per share (EPS) of companies in the S&P 500. However, Trump isn’t looking for a small reduction in taxes… he’s targeting a 20% drop. Let’s assume he settles for a rate in the middle, a 10% cut. EPS for the companies in the S&P 500 could then be about $146. A P/E ratio of 17 provides a price target of about 2,500. A P/E ratio of 20, which could easily be justified by… Read More

Few industries have been hit as hard as pharmaceuticals over the past year. From public outrage over price increases to the potential for government oversight into profits, the group hasn’t enjoyed the double-digit gains seen across the rest of the market. Drugmakers and investors thought they dodged a bullet in the presidential election, but the new administration has been just as vocal about drug prices as the last. In this darkest hour, there may be some light shining through to the rest of the year. A new leader at the Food and Drug Administration (FDA) could end the industry’s drought… Read More

Few industries have been hit as hard as pharmaceuticals over the past year. From public outrage over price increases to the potential for government oversight into profits, the group hasn’t enjoyed the double-digit gains seen across the rest of the market. Drugmakers and investors thought they dodged a bullet in the presidential election, but the new administration has been just as vocal about drug prices as the last. In this darkest hour, there may be some light shining through to the rest of the year. A new leader at the Food and Drug Administration (FDA) could end the industry’s drought of approvals. The fundamental shift to an older society continues to support higher sales and Washington has yet to put together a plan that would threaten pricing. I’ve been following the best-of-breed companies in the space, waiting for a potential turnaround in investor sentiment. That turnaround may be coming — and it could happen just as two leaders boost sales with new blockbuster drugs. Pharma Is Ready To Bounce Back Pharmaceutical companies have been rocked over the past year on regulatory oversight and patient anger over drug pricing. The PowerShares Dynamic Pharmaceuticals ETF (NYSE: PJP) is up just 2.8%… Read More

These days, any time a big-name company (most often a “hot tech stock”) files its initial registration to become a publicly traded company, I field inquiries from friends, family and readers on what my thoughts are regarding said company — even though I already know that the majority of these folks have already made up their minds and will likely ignore my advice… That’s because what I tell them isn’t what they want to hear. So they’ll disregard and seek opinions that match their own. This is called confirmation bias. This scenario played out when popular social-media company Snapchat (NYSE:… Read More

These days, any time a big-name company (most often a “hot tech stock”) files its initial registration to become a publicly traded company, I field inquiries from friends, family and readers on what my thoughts are regarding said company — even though I already know that the majority of these folks have already made up their minds and will likely ignore my advice… That’s because what I tell them isn’t what they want to hear. So they’ll disregard and seek opinions that match their own. This is called confirmation bias. This scenario played out when popular social-media company Snapchat (NYSE: SNAP) went public March 2. For the uninitiated, Snapchat is basically a platform that allows you to use the camera on your phone to send pictures or short videos (aka “snaps”) to your friends or the public at large, along with a host of animations and effects that allow the user to enhance their image or story. Then, once a friend views the snap, it will disappear. (For more information, ask a kid.) The video-messaging app raised $3.4 billion in its initial public offering (IPO), making it the biggest social-media IPO since Twitter (NYSE: TWTR) went public in early 2014. Read More

Janet Yellen just launched a nuclear missile into the heart of Social Security. You see, the Federal Reserve announced a 25 basis-point increase in the fed funds rate last Wednesday. At the same time, she made known the Fed’s intention to raise interest rates at least two more times in 2017. Now, by all accounts, the Fed’s actions were correct. The Fed is roughly 300 basis points behind the curve on interest rates. And should the economy enter another recession, the Fed would have no ammunition with which to fight an economic downturn if rates were kept at these lows. Read More

Janet Yellen just launched a nuclear missile into the heart of Social Security. You see, the Federal Reserve announced a 25 basis-point increase in the fed funds rate last Wednesday. At the same time, she made known the Fed’s intention to raise interest rates at least two more times in 2017. Now, by all accounts, the Fed’s actions were correct. The Fed is roughly 300 basis points behind the curve on interest rates. And should the economy enter another recession, the Fed would have no ammunition with which to fight an economic downturn if rates were kept at these lows. Yellen simply had no choice. But at the same time, this increases the unfunded liabilities of Social Security by trillions. That means Social Security’s troubles will show up much sooner than the trustees’ estimate of 2033. Rising Interest Rates Are Bad News For Social Security The U.S. government decided a long time ago to use non-marketable Treasury bonds to replace the cash Congress removed from Social Security. Adding insult to injury, these phony bonds pay phantom interest back to Social Security. #-ad_banner-#So when Social Security went into deficit spending in 2010, some of the interest generated by the trust… Read More

It’s the number one question asked by first-time investors… Where do I start? It may seem simple, but unless you’re the one actually having to think strategically about your goals, doing the research and then deploying cash into a portfolio, it’s easy to forget just how paralyzing this situation can be. There are many reasons this paralysis sets in. With literally thousands of mutual funds, ETFs, bonds, stocks, and other financial products to choose from, it could simply be the tyranny of too many choices, as it were. It could also be that the memories of losses experienced during the… Read More

It’s the number one question asked by first-time investors… Where do I start? It may seem simple, but unless you’re the one actually having to think strategically about your goals, doing the research and then deploying cash into a portfolio, it’s easy to forget just how paralyzing this situation can be. There are many reasons this paralysis sets in. With literally thousands of mutual funds, ETFs, bonds, stocks, and other financial products to choose from, it could simply be the tyranny of too many choices, as it were. It could also be that the memories of losses experienced during the most recent financial crisis are still too raw. And now, especially with major market averages near all-time highs, it can be even more difficult to know what to do. #-ad_banner-#Whatever the reason, simply not knowing where to start is the single biggest problem investors face. It’s also the one I’m personally asked about most often — and one I was personally confronted with just recently yet again. My grandmother had asked me to help her invest a small sum of money for her. It’s certainly not a fortune — but it’s no small sum either, at least not to her… Read More

For the past three years, I’ve driven an SUV and a pickup. I got an unbelievable deal on the pickup (I always buy used), but it needed new tires. When I took the truck to the friendly neighborhood tire guys to replace them with similar all-terrain tires, I then understood why they were so friendly and why the truck was such a good deal. Ouch. I’m not alone. Currently, light trucks and SUVs represent 63% of 2016’s record year for U.S. vehicle sales, which came in at 17.55 million. Three years ago, the truck and SUV share of auto sales… Read More

For the past three years, I’ve driven an SUV and a pickup. I got an unbelievable deal on the pickup (I always buy used), but it needed new tires. When I took the truck to the friendly neighborhood tire guys to replace them with similar all-terrain tires, I then understood why they were so friendly and why the truck was such a good deal. Ouch. I’m not alone. Currently, light trucks and SUVs represent 63% of 2016’s record year for U.S. vehicle sales, which came in at 17.55 million. Three years ago, the truck and SUV share of auto sales was right at 50%. As far as cars on the road in the United States, the average age of a vehicle in the light truck/SUV category is around 6.1 years. Eventually, tens of millions of tires will be replaced to the tune of $800 to $1,400 a set. That’s why I’m looking at Cooper Tire and Rubber Company (NYSE: CTB). Cooper is the number five tire manufacturer in North America and number twelve worldwide, with 2016 sales of $2.92 billion. Why do I want to buy the middle of the pack? First, the stock is a genuine value with attractive… Read More

At my premium newsletter Game-Changing Stocks, I have the challenging but exciting task of identifying companies that are set to change the way the world operates. I’m talking about companies that hold the promise of revolutionizing their specific sectors of the economy or companies that create and nurture promising new businesses. And, of course, these are companies that will richly reward investors. #-ad_banner-#If there’s one thing true game-changers have in common, it’s the ability to innovate. But it’s not just companies that are innovative — countries can be, too. An innovation-friendly environment on a country level should, in theory, do… Read More

At my premium newsletter Game-Changing Stocks, I have the challenging but exciting task of identifying companies that are set to change the way the world operates. I’m talking about companies that hold the promise of revolutionizing their specific sectors of the economy or companies that create and nurture promising new businesses. And, of course, these are companies that will richly reward investors. #-ad_banner-#If there’s one thing true game-changers have in common, it’s the ability to innovate. But it’s not just companies that are innovative — countries can be, too. An innovation-friendly environment on a country level should, in theory, do wonders for companies domiciled in this country. Therefore, it should end up benefitting investors, too. So to complement my growing set of promising companies in Game-Changing Stocks, I recently featured a look at a highly innovative country that holds promise of fostering as many game-changing ideas as possible. It’s not a coincidence that so many revolutionary technologies, processes, consumer goods, medicines and devices originated here in the United States: Our country spends a big chunk of its GDP on research & development (R&D). The National Science Foundation put the number at a record $499 billion in 2015. Of that amount,… Read More

Now is the time to get long oil. This is a big change for me; I was a huge oil bear during the “peak oil” craze. It seemed clear that the new extraction technology and the ever-changing geopolitical climate would quickly eliminate the fear of oil becoming scarce. But my investment thesis, to buck oils upward trend, came to fruition faster than I expected. #-ad_banner-#The Light Crude Oil futures contract (WTI Crude) plunged from the $115.00 zone at the start of 2011 to just above $25.00 in the early months of 2016. The bulk of the dive began in mid-2014,… Read More

Now is the time to get long oil. This is a big change for me; I was a huge oil bear during the “peak oil” craze. It seemed clear that the new extraction technology and the ever-changing geopolitical climate would quickly eliminate the fear of oil becoming scarce. But my investment thesis, to buck oils upward trend, came to fruition faster than I expected. #-ad_banner-#The Light Crude Oil futures contract (WTI Crude) plunged from the $115.00 zone at the start of 2011 to just above $25.00 in the early months of 2016. The bulk of the dive began in mid-2014, with a precipitous fall to the lows. Fortunes were made by the oil bears who had the foresight and nerve to short in the face of massive bullish sentiment. The oil sell-off was the primarily the result of a trifecta of factors. First, technology led to a flood of product onto the market. New extraction techniques, such as fracking, allowed producers to access untold barrels of black gold never imagined by the oil bulls. The earth went from potentially running out of oil within our lifetime to virtually unlimited supplies. Second, political events drove prices down. At the start of… Read More